- Home
- LTRN vs ADIL Comparison
LTRN vs ADIL Comparison
Compare LTRN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTRN | ADIL |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 10.2M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LTRN | ADIL |
|---|---|---|
| Price | $0.65 | $4.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $17.50 | $8.33 |
| AVG Volume (30 Days) | ★ 263.4K | 31.6K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.65 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.59 | $0.13 |
| 52 Week High | $4.34 | $8.75 |
Technical Indicators
Market Signals| Indicator | LTRN | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 31.02 | 62.80 |
| Support Level | $0.59 | $3.80 |
| Resistance Level | $1.96 | $6.26 |
| Average True Range (ATR) | 0.09 | 0.45 |
| MACD | 0.05 | 0.15 |
| Stochastic Oscillator | 24.02 | 95.35 |
Price Performance
Historical ComparisonAbout LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.